12 June 2008 – Phlexglobal, the specialist CRO for clinical trial administration and study support, announces a new board of directors to help continue the company’s unprecedented growth.
The new board will be led by Phlexglobal founder and chief executive officer Nicola Murgatroyd. Joining Nicola on the board is Karen Roy, who successfully launched the company’s PhlexEviewTM solution last year, and has taken up the position of global business development director.
Also joining the board are Stella Donoghue, recently appointed as finance director, and Nigel Murgatroyd who takes up the position of commercial director. Stella specialises in supporting entrepreneurial SME’s in their high growth phase which, together with Nigel’s extensive commercial experience, will facilitate Phlexglobal’s ventures into new markets and territories. Ray Clarke, founder and managing director of Datacare Business Systems Ltd, and Stephen Swiatek, UK sales director with a pan-European German company both join as non-executive directors.
Chief executive officer, Nicola Murgatroyd, commented, “The time is right to share the running of the company and, together with Nigel, I am delighted to welcome Stella, Karen, Ray and Stephen to the board. With them, I am looking forward to continuing Phlexglobal’s tradition of clinical study support leadership and innovation in the pharmaceutical sector and working to achieve our next stage of growth.”
Experts in clinical document management, resourcing, training, archiving and general study support services, Phlexglobal counts 15 of the top 20 pharmaceutical companies across the globe as its clients. Complementing these core clinical support services, the company provides an electronic solution offering centralised management of Trial Master File documentation.
Over the past 24 months, Phlexglobal has doubled in size with a turnover forecast of £5m for 2008 rising to £10m by 2010. The company has developed a range of unique flexible resourcing models, including their unique Task Force services, and consolidated their service delivery approach to ensure clients are supported in delivering ever greater efficiencies throughout the clinical trial process as required by today’s competitive environment.
Phlexglobal is now looking to build on the strong foundations now in place with its new board of directors and pursue its goal to be the provider of choice for flexible staffing and e-TMF and document solutions to the clinical research industry.
For further information about Phlexglobal and its services log on to www.phlexglobal.com.
For further information, please contact:
BCS Public Relations
Tel: 0115 9486901
Email: [email protected]